Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. IHE: which is better?

Bottom line

XLV vs IHE: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and IHE (iShares U.S. Pharmaceuticals ETF) share a meaningful slice of their top holdings — about 42% by weight.

XLV is cheaper at 0.08% vs 0.37% — a difference of $29 a year per $10,000 invested.

Over five years, IHE returned +9.1% a year vs +8.1% for XLV.

Updated Nov 19, 2026

XLV vs IHE side by side

XLVIHE
TypeETFETF
Fund familySPDR (State Street)iShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.37%
Annual cost per $10k$8$37
10-yr cost on $10k (prospectus)$103$468
Max front loadNoneNone
12b-1 fee0.02%0%
1-yr return+14.5%+31.7%
5-yr return (annualized)+8.1%+9.1%
10-yr return (annualized)+9.8%+6.2%
Best quarter+14.5%+17.6%
Worst quarter−12.7%−16.0%
Net assets (fund)$40.6B$1.1B
Number of holdings6559
Portfolio turnover2%29%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVIHEDifference
2025+14.5%+31.7%−17.2%
2024+2.5%+8.1%−5.6%
2023+2.0%+1.0%+1.0%
2022−2.1%−4.8%+2.7%
2021+25.9%+12.8%+13.1%
2020+13.3%+13.8%−0.5%
2019+20.7%+15.5%+5.2%
2018+6.3%−7.7%+14.0%
2017+21.7%+10.7%+11.0%
2016−2.8%−11.7%+8.9%

Source: Fund prospectus bar charts

Holdings overlap

5 of XLV's top 25 holdings also appear in IHE's top 25.

Shared top holdings
HoldingXLVIHE
Eli Lilly & Co16.51%22.25%
Johnson & Johnson10.64%22.44%
Merck & Co Inc5.52%4.55%
Pfizer Inc2.39%3.96%
Bristol-Myers Squibb Co2.05%4.37%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

IHE top 10

  1. Johnson & Johnson — 22.44%
  2. Eli Lilly And Company — 22.25%
  3. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
  4. Merck & Co., Inc. — 4.55%
  5. Bristol-myers Squibb Company — 4.37%
  6. Royalty Pharma Plc — 4.34%
  7. Viatris Inc. — 4.22%
  8. Pfizer Inc. — 3.96%
  9. Zoetis Inc. — 3.73%
  10. Jazz Pharmaceuticals Public Limited Company — 3.45%

FAQ

What is the difference between XLV and IHE?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and IHE (iShares U.S. Pharmaceuticals ETF) share a meaningful slice of their top holdings — about 42% by weight. XLV is cheaper at 0.08% vs 0.37% — a difference of $29 a year per $10,000 invested.
Which is cheaper, XLV or IHE?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and IHE?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.